Comparison of risedronate versus placebo in preventing anastrozole-induced bone loss in women at high risk of developing breast cancer with osteopenia

Anastrozole has been shown to prevent breast cancer in postmenopausal women at high risk of the disease, but has been associated with substantial accelerated loss of bone mineral density (BMD) and increased fractures. Here, we investigate the effect of risedronate on BMD after 5 years of follow-up i...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Bone
Main Authors: Sestak, Ivana, Blake, Glen M., Patel, Rajesh, Coleman, Robert E., Cuzick, Jack, Eastell, Richard
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier Science 2019
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6548284/
https://ncbi.nlm.nih.gov/pubmed/31028957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2019.04.016
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker